115 related articles for article (PubMed ID: 12830551)
1. [Review of cut-off points between stages T1 and T2 in the 1997 TNM classification of renal carcinoma].
López Luque AJ; Anglada Curado FJ; Carazo Carazo JL; Alvarez Kindelan J; Márquez López J; Leva Vallejo M; Regueiro López JC; Prieto Castro R; Requena Tapia MJ
Actas Urol Esp; 2003 Apr; 27(4):292-6. PubMed ID: 12830551
[TBL] [Abstract][Full Text] [Related]
2. Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome.
Zisman A; Pantuck AJ; Chao D; Dorey F; Said JW; Gitlitz BJ; de Kernion JB; Figlin RA; Belldegrun AS
J Urol; 2001 Jul; 166(1):54-8. PubMed ID: 11435822
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
Belldegrun A; Tsui KH; deKernion JB; Smith RB
J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of tumour size in patients after tumour nephrectomy for localised renal cell carcinoma.
Steiner T; Knels R; Schubert J
Eur Urol; 2004 Sep; 46(3):327-30. PubMed ID: 15306102
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the 1997 TNM classification of renal cell carcinoma.
Javidan J; Stricker HJ; Tamboli P; Amin MB; Peabody JO; Deshpande A; Menon M; Amin MB
J Urol; 1999 Oct; 162(4):1277-81. PubMed ID: 10492179
[TBL] [Abstract][Full Text] [Related]
6. The impact of a 4 cm. cutoff point for stratification of T1N0M0 renal cell carcinoma after radical nephrectomy.
Igarashi T; Tobe T; Nakatsu HO; Suzuki N; Murakami S; Hamano M; Maruoka M; Nagayama T; Matsuzaki O; Ito H
J Urol; 2001 Apr; 165(4):1103-6. PubMed ID: 11257647
[TBL] [Abstract][Full Text] [Related]
7. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
[TBL] [Abstract][Full Text] [Related]
8. Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent.
Gilbert SM; Murphy AM; Katz AE; Goluboff ET; Sawczuk IS; Olsson CA; Benson MC; McKiernan JM
Urology; 2006 Aug; 68(2):287-91. PubMed ID: 16904438
[TBL] [Abstract][Full Text] [Related]
9. Stage pT1 renal cell carcinoma: review of the prognostic significance of size.
Zucchi A; Mearini L; Mearini E; Costantini E
Urol Int; 2003; 70(1):47-50. PubMed ID: 12566815
[TBL] [Abstract][Full Text] [Related]
10. Impact of tumor size on the clinical outcomes of patients with Robson State I renal cell carcinoma.
Kinouchi T; Saiki S; Meguro N; Maeda O; Kuroda M; Usami M; Kotake T
Cancer; 1999 Feb; 85(3):689-95. PubMed ID: 10091742
[TBL] [Abstract][Full Text] [Related]
11. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
[TBL] [Abstract][Full Text] [Related]
12. The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma.
Svatek RS; Lotan Y; Herman MP; Duchene DA; Sagalowsky AI; Cadeddu JA
J Urol; 2006 Oct; 176(4 Pt 1):1321-5; discussion 125. PubMed ID: 16952621
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor size on the long-term survival of patients with early stage renal cell cancer.
Kuczyk M; Wegener G; Merseburger AS; Anastasiadis A; Machtens S; Zumbrägel A; Hartmann JT; Bokemeyer C; Jonas U; Stenzl A
World J Urol; 2005 Feb; 23(1):50-4. PubMed ID: 15729558
[TBL] [Abstract][Full Text] [Related]
14. Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system.
Gettman MT; Blute ML; Spotts B; Bryant SC; Zincke H
Cancer; 2001 Jan; 91(2):354-61. PubMed ID: 11180082
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
[TBL] [Abstract][Full Text] [Related]
16. Does tumor size or microvascular invasion affect prognosis in patients with renal cell carcinoma?
Miyagawa T; Shimazui T; Hinotsu S; Oikawa T; Sekido N; Miyanaga N; Kawai K; Akaza H
Jpn J Clin Oncol; 2007 Mar; 37(3):197-200. PubMed ID: 17360737
[TBL] [Abstract][Full Text] [Related]
17. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.
Siemer S; Lehmann J; Loch A; Becker F; Stein U; Schneider G; Ziegler M; Stöckle M
J Urol; 2005 Jan; 173(1):33-7. PubMed ID: 15592020
[TBL] [Abstract][Full Text] [Related]
18. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
19. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
20. Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy.
Chen L; Ma X; Li H; Gu L; Li X; Gao Y; Xie Y; Zhang X
PLoS One; 2017; 12(3):e0173953. PubMed ID: 28288191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
